Published in TB and Outbreaks Week, July 8th, 2008
"Our study attempted to characterize the immune profiles of patients with PKDL or VL relative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.